Circular RNA-encoded peptides and proteins: implications to cancer.
- Author:
Shuang Ao KE
1
;
Shengnan ZHAO
1
;
Yu LIU
1
;
Qing ZHUO
1
;
Xiangwen TONG
1
;
Yao XU
1
Author Information
- Publication Type:Review
- Keywords: cancer; circRNA-encoded proteins; circular RNA; internal ribosome entry site; m6A modification
- MeSH: Humans; Internal Ribosome Entry Sites; Neoplasms/genetics*; Peptides, Cyclic; RNA/genetics*; RNA, Circular/genetics*
- From: Chinese Journal of Biotechnology 2022;38(9):3131-3140
- CountryChina
- Language:Chinese
- Abstract: Circular RNA (circRNA) is a single-stranded circular closed RNA molecule formed from linear RNA through reverse splicing. circRNAs are stable, highly conserved, and tissue-specific. circRNAs can regulate physiological and pathological processes through various mechanisms such as formation of competing endogenous RNA and interaction with binding proteins. It has been recently revealed that circRNAs can be translated into peptides and proteins to participate in the initiation and development of cancer. circRNAs are promising diagnostic and prognostic markers for human cancers as well as potential drug targets for cancer therapy. This review summarized the research progresses related to circRNA-encoded peptides and proteins in a variety of cancers. These peptides and proteins are translated through two different mechanisms that depend on internal ribosome entry site and m6A, respectively. We also summarized the potential use of circRNA-encoded peptides and proteins in the diagnosis, treatment, prognosis and mechanistic studies of various cancers.
